Published in Transplant Proc on April 01, 1994
Structural-functional relationships in diabetic nephropathy. J Clin Invest (1984) 4.78
Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med (1998) 4.30
20 years or more of follow-up of living kidney donors. Lancet (1992) 3.88
Assessing the implementation of physician-payment reform. N Engl J Med (1993) 3.71
Limiting financial disincentives in live organ donation: a rational solution to the kidney shortage. Am J Transplant (2006) 3.31
Pregnancy outcomes after kidney donation. Am J Transplant (2009) 2.66
Pancreatico-duodenal allotransplantation: experimental and clinical experience. Ann Surg (1970) 2.44
Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med (1982) 2.44
Organ donation in three major American cities with large Latino and black populations. Transplantation (1988) 2.41
The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation (1987) 2.40
Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med (1990) 2.32
Immunologic and nonimmunologic factors: different risks for cadaver and living donor transplantation. Transplantation (2000) 2.25
Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res (1981) 2.25
An overview of the development and refinement of the Resource-Based Relative Value Scale. The foundation for reform of U.S. physician payment. Med Care (1992) 2.24
Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology (1985) 2.18
A mammalian equivalent of the avian bursa of Fabricius. Lancet (1966) 2.11
Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol (1997) 2.09
Development of "autoimmune processes" in rabbits after neonatal removal of central lymphoid tissue. Lancet (1965) 2.04
American Society of Transplant Surgeons transplant center outcomes requirements--a threat to innovation. Am J Transplant (2009) 2.00
Transplantation of discordant xenografts: a review of progress. Immunol Today (1990) 2.00
Cytomegalovirus (CMV) antigenemia assay is more sensitive than shell vial cultures for rapid detection of CMV in polymorphonuclear blood leukocytes. J Clin Microbiol (1992) 1.99
Risk factors for chronic rejection in renal allograft recipients. Transplantation (1993) 1.90
Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg (2001) 1.89
Cytomegalovirus-induced immune suppression. I. Humoral immunity. Clin Exp Immunol (1974) 1.86
Association of renal allograft rejection with virus infections. Am J Med (1974) 1.83
Vascular graft thrombosis after pancreatic transplantation: univariate and multivariate operative and nonoperative risk factor analysis. J Am Coll Surg (1996) 1.83
Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest (1985) 1.80
Increased incidence of malignancy during chronic renal failure. Lancet (1975) 1.79
The surgical risk of pancreas transplantation in the cyclosporine era: an overview. J Am Coll Surg (1997) 1.79
Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome. J Am Coll Surg (1996) 1.75
Studies of the rate of regression of the glomerular lesions in diabetic rats treated with pancreatic islet transplantation. Diabetes (1975) 1.74
Preserved insulin secretion and insulin independence in recipients of islet autografts. N Engl J Med (1992) 1.74
Are wound complications after a kidney transplant more common with modern immunosuppression? Transplantation (2001) 1.73
Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet (1972) 1.71
Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys. Lancet (1993) 1.70
The process of microbial translocation. Ann Surg (1990) 1.69
Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. Science (1976) 1.65
Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation (1995) 1.65
Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. N Engl J Med (1988) 1.65
Long-term follow-up of living kidney donors: quality of life after donation. Transplantation (1999) 1.65
Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. Am J Transplant (2010) 1.65
Hepatic resection for secondary neoplasms. Surgery (1982) 1.64
Complications and risks of living donor nephrectomy. Transplantation (1997) 1.61
Human immunodeficiency virus infection in patients with solid-organ transplants: report of five cases and review. Rev Infect Dis (1991) 1.58
The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation (1994) 1.58
Cytomegalovirus-induced immune suppression. II. Cell-mediated immunity. Clin Exp Immunol (1974) 1.55
Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. N Engl J Med (1990) 1.53
The Epstein-Barr virus in the pathogenesis of posttransplant lymphoproliferative disorders. Clinical, pathologic, and virologic correlation. Surgery (1981) 1.53
Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients. Clin Infect Dis (1995) 1.53
Pancreatitis and hyperparathyroidism. Br J Surg (1988) 1.52
Improved islet isolation from rat pancreas using 35% bovine serum albumin in combination with Dextran gradient separation. Transplantation (1996) 1.51
Cell and matrix components of the glomerular mesangium in type I diabetes. Diabetes (1992) 1.51
Colon perforation after renal transplantation: a single-institution review. Clin Transplant (1997) 1.47
Successful transplantation after conversion of a positive crossmatch to negative by dissociation of IgM antibody. Transplantation (1989) 1.46
Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery (1977) 1.45
Fractionated total lymphoid irradiation as preparative immunosuppression in high risk renal transplantation: clinical and immunological studies. Ann Surg (1982) 1.44
Pancreas after kidney transplants. Am J Surg (2001) 1.44
Prolonged preservation increases surgical complications after pancreas transplants. Surgery (2000) 1.44
Selective retransplant after graft loss to nonadherence: success with a second chance. Am J Transplant (2009) 1.44
Bactericidal and endotoxin neutralizing activity of a peptide derived from Limulus antilipopolysaccharide factor. Surgery (2000) 1.43
Circadian variation in the rejection of rat kidney allografts. Surgery (1973) 1.43
Steroid diabetes in renal transplant recipients: pathogenetic factors and prognosis. Surgery (1973) 1.43
A rapid method for purification of large quantities of anti-lymphocytic serum. Proc Soc Exp Biol Med (1967) 1.42
Intra-abdominal infections in pancreas transplant recipients. Ann Surg (1986) 1.42
Systemic fat embolism after renal homotransplantation and treatment with corticosteroids. N Engl J Med (1965) 1.42
2,500 living donor kidney transplants: a single-center experience. Ann Surg (2001) 1.41